Hikma Pharmaceuticals Share News (HIK)

Sports Direct to drop out of FTSE 100 in reshuffle

* WM Morrison, Paddy Power and Betfair to join FTSE 100 * Informa and Mediclinic to also join FTSE 100 * Sports Direct, Aberdeen AM, Smiths, Hikma drop out * Changes will take effect on March 21 By Sudip Kar-Gupta LONDON, March 2 (Reuters) - Sports Direct and Aberdee

Paddy Power Betfair, Mediclinic, Informa And Morrisons Join FTSE 100

Morrisons set for FTSE 100 return, Sports Direct in line for demotion

(ShareCast News) - Morrisons, which announced a new grocery supply deal with Amazon.com on Monday, may work its way back into the FTSE 100 this month. The supermarket retailer, which was booted out at the last quarterly review, could be joined by newly-merged Paddy Power Betfair and private hospital

U.S. sets conditions for Hikma's takeover of Boehringer's Roxane

WASHINGTON, Feb 26 (Reuters) - Drug manufacturer Hikma Pharmaceuticals Plc will sell the rights and assets of two generic drugs and relinquish its U.S. marketing rights to a third generic drug in order to settle Federal Trade Commission charges that Hikma's proposed $2 billion acquisition of Roxa

Hikma hires well-connected American

(ShareCast News) - Hikma Pharmaceuticals has appointed US public affairs veteran John Castellani to its board. The FTSE 100 pharmaceuticals company said the appointment, which is effective from March 1, will see him join the the audit, remuneration, and compliance, responsibility and ethics committe

WINNERS & LOSERS SUMMARY: HSBC Warns Of "Bumpier" Road For Finance

Hikma Pharmaceuticals Appoints Ex-US Industry Body Chief To Board

BROKER RATINGS SUMMARY: Macquarie Starts Burberry At Outperform

LONDON BRIEFING: Coca-Cola HBC And Standard Life Impress With Results

BROKER RATINGS SUMMARY: JPMorgan Raises Auto Trader To Overweight

AGM, EGM Calendar - Week Ahead

BROKER RATINGS SUMMARY: Panmure Gordon Raises DCC To Buy After Update

FTSE 100 movers: Housebuilders lead market higher

(ShareCast News) - The FTSE 100 was set to turn things around on Wednesday, with the blue chip market up 48.39 points (0.86%) to 5,680.58 by mid-afternoon. Housebuilders were on the rise, including Taylor Wimpey, Berkeley Group Holdings and Barratt Developments, after sector peer Bellway reported st

LONDON MARKET MIDDAY: Stocks Up As Investors Await Yellen's Testimony

UPDATE 3-Hikma cuts offer for Boehringer's U.S. generic drug unit

* Hikma agrees with Boehringer on lower price for Roxane * Cash component of initially $1.18 bln cut by $535 mln * Roxane's 2016 sales now seen below 2015 levels (Adds Boehringer statement, bullet points, rebates) By Noor Zainab Hussain and Esha Vaish Feb 10 (Reuters) -